Drug Shortage Report for MED-BRIMONIDINE
Report ID | 166353 |
Drug Identification Number | 02507811 |
Brand name | MED-BRIMONIDINE |
Common or Proper name | Brimonidine 0.2% w/v 5 and 10 ml bottle |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.2% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5ml bottle and 10 ml bottle |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-08-01 |
Actual start date | 2022-08-08 |
Estimated end date | 2022-11-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-08-09 | English | Compare |
v2 | 2022-08-08 | French | Compare |
v1 | 2022-08-08 | English | Compare |
Showing 1 to 3 of 3